These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8359032)

  • 61. Changes in lysyl oxidase (LOX) distribution and its decreased activity in keratoconus corneas.
    Dudakova L; Liskova P; Trojek T; Palos M; Kalasova S; Jirsova K
    Exp Eye Res; 2012 Nov; 104():74-81. PubMed ID: 23041260
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
    Iwata H; Kobayashi S; Iwase H; Masaoka A; Fujimoto N; Okada Y
    Jpn J Cancer Res; 1996 Jun; 87(6):602-11. PubMed ID: 8766524
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Secreted inhibitors of metalloproteinases (IMPs) that are distinct from TIMP.
    Banda MJ; Howard EW; Herron GS; Apodaca G
    Matrix Suppl; 1992; 1():294-8. PubMed ID: 1480040
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Changes in the balance of the tissue inhibitor of matrix metalloproteinases (TIMPs)-1 and -3 may promote keratocyte apoptosis in keratoconus.
    Matthews FJ; Cook SD; Majid MA; Dick AD; Smith VA
    Exp Eye Res; 2007 Jun; 84(6):1125-34. PubMed ID: 17449031
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neutrophil elastase processing of gelatinase A is mediated by extracellular matrix.
    Rice A; Banda MJ
    Biochemistry; 1995 Jul; 34(28):9249-56. PubMed ID: 7619826
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Expression and activity of MMPS and their regulators in ovarian cancer.
    Naylor MS; Stamp GW; Davies BD; Balkwill FR
    Int J Cancer; 1994 Jul; 58(1):50-6. PubMed ID: 8014015
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.
    Di Girolamo N; Lloyd A; McCluskey P; Filipic M; Wakefield D
    Am J Pathol; 1997 Feb; 150(2):653-66. PubMed ID: 9033278
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hormonal regulation of matrix metalloproteinase inhibitors in rat granulosa cells and ovaries.
    Mann JS; Kindy MS; Edwards DR; Curry TE
    Endocrinology; 1991 Apr; 128(4):1825-32. PubMed ID: 1848503
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Large inhibitor of metalloproteinases (LIMP) contains tissue inhibitor of metalloproteinases (TIMP)-2 bound to 72,000-M(r) progelatinase.
    Curry VA; Clark IM; Bigg H; Cawston TE
    Biochem J; 1992 Jul; 285 ( Pt 1)(Pt 1):143-7. PubMed ID: 1637293
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas.
    Nomura H; Fujimoto N; Seiki M; Mai M; Okada Y
    Int J Cancer; 1996 Feb; 69(1):9-16. PubMed ID: 8600068
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y; Yeon J; Kim HJ; Lee ST
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chondrocyte cultures express matrix metalloproteinase mRNA and immunoreactive protein; stromelysin-1 and 72 kDa gelatinase are localized in extracellular matrix vesicles.
    Schmitz JP; Dean DD; Schwartz Z; Cochran DL; Grant GM; Klebe RJ; Nakaya H; Boyan BD
    J Cell Biochem; 1996 Jun; 61(3):375-91. PubMed ID: 8761942
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells.
    Li YY; McTiernan CF; Feldman AM
    Cardiovasc Res; 1999 Apr; 42(1):162-72. PubMed ID: 10435007
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Regulation of collagen degradation in the rat myocardium after infarction.
    Cleutjens JP; Kandala JC; Guarda E; Guntaka RV; Weber KT
    J Mol Cell Cardiol; 1995 Jun; 27(6):1281-92. PubMed ID: 8531210
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cathepsin G, acid phosphatase, and alpha 1-proteinase inhibitor messenger RNA levels in keratoconus corneas.
    Whitelock RB; Fukuchi T; Zhou L; Twining SS; Sugar J; Feder RS; Yue BY
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):529-34. PubMed ID: 9040486
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A novel matrix-degrading protease in hormone-dependent breast cancer.
    Dickson RB; Shi YE; Johnson MD
    Biochem Soc Trans; 1994 Feb; 22(1):49-52. PubMed ID: 8206274
    [No Abstract]   [Full Text] [Related]  

  • 77. Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines.
    Kawamata H; Nakashiro K; Uchida D; Harada K; Yoshida H; Sato M
    Int J Cancer; 1997 Jan; 70(1):120-7. PubMed ID: 8985100
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Gelatinase is the main matrix metalloproteinase involved in granuloma-induced cartilage degradation.
    Trancart MM; Chalmeigne N; Girardot C; Zarpanelian C; Prigent D
    Int J Tissue React; 1992; 14(6):287-94. PubMed ID: 1339118
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Metalloproteinase and TIMP-1 gene expression during replicative senescence.
    Millis AJ; McCue HM; Kumar S; Baglioni C
    Exp Gerontol; 1992; 27(4):425-8. PubMed ID: 1459220
    [No Abstract]   [Full Text] [Related]  

  • 80. Efficient purification of TIMP-2 from culture medium conditioned by human hepatoma cell line, and its inhibitory effects on metalloproteinases and in vitro tumor invasion.
    Umenishi F; Umeda M; Miyazaki K
    J Biochem; 1991 Aug; 110(2):189-95. PubMed ID: 1662201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.